Updates on HR-positive HER2-negative breast cancer

Haematology malignancies and cellular therapy

Social determinants of health in primary care

Hodgkin’s and non-Hodgkin’s lymphomas (NHL)

Immunotherapy developments and new agents for locally advanced NSCLC and SCLC

The enhancing oncology model and other value-based propositions

GIST tumours and soft tissue sarcomas

Breast cancer and survivorship

Challenges in interpreting comprehensive biomarker testing and a few paths to address them

Addressing cancer disparities in Hispanic populations in the US and in low and middle income countries

Updates on triple-negative breast cancer and immunotherapy

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Predictive and prognostic biomarkers for immunotherapy in lung cancer

Updates in melanoma and skin cancers

Gynaecological cancer: New targets and immunotherapy developments

Molecular oncology and translational medicine

Immunotherapy in NSCLC: Adjuvant and neoadjuvant clinical scenarios

Addressing cancer disparities in Hispanic populations in the US and in LMICs